rs2867014
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_025074.7(FRAS1):c.604-8G>A variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.985 in 1,562,592 control chromosomes in the GnomAD database, including 759,364 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_025074.7 splice_region, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FRAS1 | NM_025074.7 | c.604-8G>A | splice_region_variant, intron_variant | ENST00000512123.4 | NP_079350.5 | |||
FRAS1 | NM_001166133.2 | c.604-8G>A | splice_region_variant, intron_variant | NP_001159605.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FRAS1 | ENST00000512123.4 | c.604-8G>A | splice_region_variant, intron_variant | 5 | NM_025074.7 | ENSP00000422834.2 |
Frequencies
GnomAD3 genomes AF: 0.940 AC: 142943AN: 152114Hom.: 67676 Cov.: 31
GnomAD3 exomes AF: 0.977 AC: 241753AN: 247408Hom.: 118386 AF XY: 0.981 AC XY: 131520AN XY: 134130
GnomAD4 exome AF: 0.990 AC: 1395975AN: 1410360Hom.: 691647 Cov.: 23 AF XY: 0.990 AC XY: 697982AN XY: 704850
GnomAD4 genome AF: 0.940 AC: 143040AN: 152232Hom.: 67717 Cov.: 31 AF XY: 0.941 AC XY: 70064AN XY: 74446
ClinVar
Submissions by phenotype
Fraser syndrome 1 Benign:3
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Aug 10, 2021 | - - |
Benign, no assertion criteria provided | clinical testing | Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen | - | - - |
not specified Benign:2
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Benign, no assertion criteria provided | clinical testing | Genome Diagnostics Laboratory, University Medical Center Utrecht | - | - - |
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at